Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Flufenazin
2. Fluphenazine
3. Hydrochloride, Fluphenazine
4. Lyogen
5. Prolixin
1. Fluphenazine Dihydrochloride
2. 146-56-5
3. Prolixin
4. Anatensol
5. Permitil
6. Fluphenazine (dihydrochloride)
7. Tensofin
8. Moditen
9. Squibb 4918
10. Dapotum
11. Omca
12. Fluphenazine Hcl
13. Calmansial
14. Flufenazin
15. Lyorodin
16. Liogen
17. Fluphenazine Chloride
18. Fluphenazine Dihcl
19. Fluorophenazine Dihydrochloride
20. Zou145w1xl
21. Valamina
22. 1-(2-hydroxyethyl)-4-(3-(2-trifluoromethyl-10-phenothiazinylpropyl)piperazine Dihydrochloride
23. 1-piperazineethanol, 4-(3-(2-(trifluoromethyl)-10h-phenothiazin-10-yl)propyl)-, Dihydrochloride
24. 4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-1-piperazineethanol Dihydrochloride
25. Nsc-179197
26. Trancin
27. A 4077
28. 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dihydrochloride
29. Permitil Hydrochloride
30. 10-(3-(4-(2-hydroxyethyl)piperazinyl)propyl)-2-trifluoromethylphenothiazine Dihydrochloride
31. 1-piperazineethanol, 4-[3-[2-(trifluoromethyl)-10h-phenothiazin-10-yl]propyl]-, Dihydrochloride
32. 2-(4-(3-(2-(trifluoromethyl)-10h-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanol Dihydrochloride
33. Ccris 4032
34. Nsc 62323
35. Sr-01000003048
36. Einecs 205-674-1
37. Unii-zou145w1xl
38. Nsc 179197
39. Siqualone
40. Fluphenazine 2hcl
41. Prolixin (tn)
42. 2-(4-(3-(2-(trifluoromethyl)-10h-phenothiazin-10-yl)propyl)piperazin-1-yl)ethan-1-ol Dihydrochloride
43. 2-(4-{3-[2-(trifluoromethyl)-10h-phenothiazin-10-yl]propyl}piperazin-1-yl)ethan-1-ol Dihydrochloride
44. Prestwick_225
45. Fluphenazine Hydrochloride [usp:ban:jan]
46. Schembl41634
47. Spectrum1500994
48. Chebi:5126
49. Flufenazine Hydrochloride
50. Chembl1448187
51. Dtxsid00892922
52. Hms1568p22
53. Hms1921o14
54. Bcp18079
55. Hy-a0081
56. Tox21_500555
57. S4569
58. Fluphenazine Hydrochloride (jan/usp)
59. Akos015960787
60. Ccg-212902
61. Cs-4290
62. Lp00555
63. 1-piperazineethanol, 4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-, Dihydrochloride
64. Fluphenazine Hydrochloride [jan]
65. Fluphenazine Dihydrochloride [mi]
66. Ncgc00093941-01
67. Ncgc00093941-02
68. Ncgc00093941-03
69. Ncgc00261240-01
70. Ac-12201
71. Bs-15804
72. Fluphenazine Hydrochloride [mart.]
73. Fluphenazine Hydrochloride [vandf]
74. S4569 Fluphenazine (dihydrochloride).cd
75. Fluphenazine Hydrochloride [usp-rs]
76. Fluphenazine Hydrochloride [who-dd]
77. Fluphenazine Hydrochloride [who-ip]
78. Eu-0100555
79. F1240
80. Ft-0668755
81. C72785
82. D00791
83. F 4765
84. Fluphenazine Hydrochloride [orange Book]
85. Fluphenazine Hydrochloride [usp Impurity]
86. Fluphenazine Hydrochloride [usp Monograph]
87. Fluphenazini Hydrochloridum [who-ip Latin]
88. Sr-01000003048-2
89. Sr-01000003048-9
90. W-108125
91. Fluphenazine Dihydrochloride 100 Microg/ml In Methanol
92. Q27295826
93. Z2784093501
94. Fluphenazine Dihydrochloride 1.0 Mg/ml In Methanol (as Free Base)
95. Fluphenazine Dihydrochloride, European Pharmacopoeia (ep) Reference Standard
96. Fluphenazine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
97. Fluphenazine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
98. 2-(4-(3-(2-(trifluoromethyl)-10h-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanoldihydrochloride
99. 2-(4-{3-[2-(trifluoromethyl)-10h-phenothiazin-10-yl]propyl}-1-piperazinyl)ethanol Dihydrochloride
100. 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol,dihydrochloride
101. Fluphenazine Dihydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 510.4 g/mol |
---|---|
Molecular Formula | C22H28Cl2F3N3OS |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 6 |
Exact Mass | 509.1282236 g/mol |
Monoisotopic Mass | 509.1282236 g/mol |
Topological Polar Surface Area | 55.2 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 544 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Fluphenazine hydrochloride |
PubMed Health | Fluphenazine Hydrochloride (By mouth) |
Drug Classes | Analgesic, Antipsychotic |
Drug Label | Fluphenazine hydrochloride is a trifluoromethyl phenothiazine derivative intended for the management of schizophrenia. Chemically it is 4-[3-[2-(Trifluoromethyl) phenothiazin-10-yl]propyl]-1-piperazineethanol dihydrochloride which may be represented... |
Active Ingredient | Fluphenazine hydrochloride |
Dosage Form | Elixir; Tablet; Concentrate; Injectable |
Route | Injection; Oral |
Strength | 2.5mg; 1mg; 2.5mg/ml; 2.5mg/5ml; 5mg; 5mg/ml; 10mg |
Market Status | Prescription |
Company | Pharm Assoc; Sandoz; Fresenius Kabi Usa; Lannett; Mylan |
2 of 2 | |
---|---|
Drug Name | Fluphenazine hydrochloride |
PubMed Health | Fluphenazine Hydrochloride (By mouth) |
Drug Classes | Analgesic, Antipsychotic |
Drug Label | Fluphenazine hydrochloride is a trifluoromethyl phenothiazine derivative intended for the management of schizophrenia. Chemically it is 4-[3-[2-(Trifluoromethyl) phenothiazin-10-yl]propyl]-1-piperazineethanol dihydrochloride which may be represented... |
Active Ingredient | Fluphenazine hydrochloride |
Dosage Form | Elixir; Tablet; Concentrate; Injectable |
Route | Injection; Oral |
Strength | 2.5mg; 1mg; 2.5mg/ml; 2.5mg/5ml; 5mg; 5mg/ml; 10mg |
Market Status | Prescription |
Company | Pharm Assoc; Sandoz; Fresenius Kabi Usa; Lannett; Mylan |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?